Variable | N = 52 | |
---|---|---|
n | % | |
Sex | ||
Male | 31 | 59.6 |
Female | 21 | 40.4 |
Age, years | ||
Median (range) | 66 (40–80) | |
Performance status WHO | ||
0 | 38 | 73.1 |
1 | 14 | 26.9 |
Primary site | ||
Colon | 28 | 53.8 |
Rectum | 24 | 46.2 |
Metastases | ||
Synchronous | 18 | 34.6 |
Metachronous | 34 | 65.4 |
Nunmer of metastatic site | ||
1 | 37 | 71.2 |
>1 | 15 | 28.8 |
Metastaic sites | ||
Liver | 30 | 57.7 |
Liver only | 16 | 30.8 |
Lung | 20 | 38.5 |
Peritoneum | 9 | 9.6 |
Lymph nodes | 5 | 17.3 |
Prior treatment | ||
Adjuvant chemotherapya | 20 | 38.5 |
Surgeryb | 35 | 67.3 |
Radiotheray | 0 | 0 |
KRAS status | ||
Wild type | 24/43 | 55.8 |
Mutant type | 19/43 | 44.2 |